HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Clinical trials for HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis is the first study in people to test a new oral medication called NKT3964. The main goals are to find a safe dose and see if the drug shows early signs of shrinking tumors in adults with advanced cancers that have spread and no longer respond to standard treatments. The stud…
Matched conditions: HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Breakthrough study tests four drug combos for male breast cancer
Disease control Recruiting nowThis study is testing which of four different hormone therapy combinations works best for men with early-stage breast cancer before surgery. About 60 men will receive one of the treatment combinations for about 4 months to see how their cancer responds. Researchers want to find b…
Matched conditions: HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Jose Pablo Leone • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Can a 10-Week program ease the stress of breast cancer treatment?
Symptom relief Recruiting nowThis study is testing whether a 10-week stress reduction program is practical and helpful for patients with triple-negative breast cancer. The program teaches relaxation, coping skills, and problem-solving, and also connects patients with social services for needs like transporta…
Matched conditions: HORMONE RECEPTOR NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC